A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
Travera Inc
Turning Point Therapeutics, Inc.
Agenus Inc.
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Novartis
Mayo Clinic
Mayo Clinic
Hoffmann-La Roche
City of Hope Medical Center
Aveni Foundation
MacroGenics
City of Hope Medical Center
Ocellaris Pharma, Inc.
Eli Lilly and Company
UNICANCER
Tanabe Pharma America, Inc.
Bristol-Myers Squibb
Transgene
HiFiBiO Therapeutics
Stella Pharma Corporation
TScan Therapeutics, Inc.
Bayer
M.D. Anderson Cancer Center
Actym Therapeutics, Inc.
Hadassah Medical Organization
Novartis
City of Hope Medical Center
Valo Therapeutics Oy
Epkin
Institut Bergonié
Sensei Biotherapeutics, Inc.
University of California, Irvine
Telix Pharmaceuticals (Innovations) Pty Limited
NextPoint Therapeutics, Inc.
OncoC4, Inc.
Stanford University
Sarcoma Oncology Research Center, LLC
Sarcoma Oncology Research Center, LLC
BostonGene
Stanford University
Cybrexa Therapeutics
Immunophotonics, Inc.
Agenus Inc.
BeiGene
Adaptimmune
Rain Oncology Inc
Taiho Pharmaceutical Co., Ltd.